Certified by Founder Lodge
Sparrow Pharmaceuticals, Inc.
United States - Portland, Oregon
START UP
1 Disclosed Funding Rounds $95,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sparrow Pharmaceuticals is a targeted cardiometabolic therapeutics company delivering improved outcomes for millions of patients who struggle to control their disease with current options for
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 25 ,2025 | Series B | $95,000,000 |
U.S. Venture Partners
Forbion
RiverVest Venture Partners
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
